Plainsboro, NJ, United States of America

Zheng Yang

This inventor holds 1 USPTO granted patent and 4 published patent applications and 1 EPO patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zheng Yang. Retrieved from https://idiyas.com/inventor/zheng-yang-mencd27b

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2023

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Zheng Yang: Innovator in Cancer Treatment

Introduction

Zheng Yang is a notable inventor based in Plainsboro, NJ (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of therapeutic methods.

Latest Patents

Zheng Yang holds a patent for the treatment of cancer with anti-GITR agonist antibodies. This patent outlines methods for treating cancer by administering a therapeutically effective amount of an anti-GITR antibody, either alone or in combination with an anti-PD-1 or anti-PD-L1 antibody. His work represents a promising advancement in cancer therapy.

Career Highlights

Zheng Yang is associated with Bristol-Myers Squibb Company, a leading biopharmaceutical firm. His role in the company has allowed him to focus on groundbreaking research aimed at improving cancer treatment options.

Collaborations

Zheng has collaborated with esteemed colleagues, including Suba Krishnan and Penny E. Phillips. These partnerships have fostered a collaborative environment that enhances the development of innovative cancer therapies.

Conclusion

Zheng Yang's contributions to cancer treatment through his patent and work at Bristol-Myers Squibb Company highlight his dedication to advancing medical science. His innovative approaches are paving the way for more effective cancer therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…